However, ScPGseq enabled the detection of a relapse‐fated subclone at the time of initial diagnosis and provides an understanding of the relapse in this patient, which is not infrequently seen in AML cases with low FLT3‐ITD AR. The gene discussed is FLT3; the disease is acute myeloid leukemia.